About Ariane Vasilatis
Form D filings for Zena Therapeutics in 2023 list Ariane Vasilatis as executive officer and director.
Ariane Vasilatis first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Ariane Vasilatis in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ariane Vasilatis works with at each company, as listed on that company's latest Form D.
Zena Therapeutics Inc. · Form D, Sep 7, 2023
EC
Eileen Carry
Chief Scientific Officer and director